Heartbeam Inc (BEAT) Stock Price, Quote & News

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recordi...

Industry: Health Information Services

Sector: Healthcare

Phone: 408 899 4443

Website: www.heartbeam.com

Address:

2118 Walsh Avenue, Suite 210, Santa Clara, United States

BrightStars May. 1 at 6:46 PM

$BEAT if these guys are waiting for 5/3 ER news to pull this up .12c in one day …that news better be the greatest news ever. IMO they need to lead off with something to bring this up. The clock is ticking.

1 · Reply

ACInvestorBlog May. 1 at 5:23 PM

$BEAT could explode higher again

1 · Reply

EddieNoMoney May. 1 at 4:01 PM

$BEAT it all makes sense now, what a fluff crap. The device is cleared only for detecting arrhythmia, 12 lead and MI detection is still in development stage and not cleared by FDA, that's why nobody gives a damn about this

4 · Reply

BrightStars May. 1 at 12:35 AM

$BEAT 2 more weeks like this and they get a letter. That doesn’t look good to any possible interested parties unless those parties are buying stock and they have inside info on when this product is going to start selling.

2 · Reply

Flyhai Apr. 30 at 7:51 PM

$BEAT earnings call/report update on may 13

0 · Reply

BrightStars Apr. 30 at 7:06 PM

$BEAT all I see is red … small red cracks in what was supposed to be a great plan. When will I ever learn !?! Unless this company miraculously comes out with some earthquake groundbreaking volcanic news….and it becomes a $20 success story overnight.

0 · Reply

BillionerOfKing Apr. 30 at 6:43 PM

$BEAT Current Stock Price: $0.87

0 · Reply

peekaboo2 Apr. 30 at 6:38 PM

$BEAT This ER won't be the one that shows much on the revenue side. But the next or the following one will for sure. As they're still working through the limited launch and the data from that isn't completely in yet. Though this stock has massive potential in the coming years. Yes, initial growth. But once subscriptions start rolling in daily news stories of additional places using the devices are going to keep this one pegging the top of the line for many years to come. Once standard of care is achieved through increased usage of the AI cloud service for ambulatory monitoring. Should make us a lot of profit for holding.

1 · Reply

BrightStars Apr. 30 at 6:33 PM

$BEAT whooo hoooo .87c HA ! POS :-/

1 · Reply

TheRoost3r Apr. 30 at 5:03 PM

$BEAT someone just got "excited" lol

0 · Reply

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

Apr 16, 2026, 4:05 PM EDT - 15 days ago

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

Apr 14, 2026, 10:00 PM EDT - 17 days ago

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

Apr 14, 2026, 4:05 PM EDT - 17 days ago

HeartBeam Announces Proposed Public Offering of Common Stock

Mar 16, 2026, 11:20 AM EDT - 6 weeks ago

HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 12, 2026, 4:30 PM EDT - 7 weeks ago

HeartBeam Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:01 PM EDT - 7 weeks ago

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Mar 10, 2026, 9:33 AM EDT - 7 weeks ago

Heartbeam Stock Jumps After AI Collaboration With Mount Sinai

Mar 10, 2026, 7:00 AM EDT - 7 weeks ago

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

Mar 9, 2026, 7:00 AM EDT - 7 weeks ago

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

Mar 5, 2026, 7:00 AM EST - 2 months ago

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

Mar 4, 2026, 4:01 PM EST - 2 months ago

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

Mar 4, 2026, 7:00 AM EST - 2 months ago

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

Jan 22, 2026, 7:00 AM EST - 3 months ago

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Jan 5, 2026, 7:00 AM EST - 4 months ago

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Dec 10, 2025, 11:27 AM EST - 5 months ago

Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

Dec 10, 2025, 7:00 AM EST - 5 months ago

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Nov 26, 2025, 4:32 PM EST - 5 months ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Nov 13, 2025, 4:30 PM EST - 6 months ago

HeartBeam Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:01 PM EST - 6 months ago

HeartBeam Reports Third Quarter 2025 Results

Oct 30, 2025, 7:00 AM EDT - 6 months ago

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time

Oct 28, 2025, 7:00 AM EDT - 6 months ago

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

Sep 8, 2025, 7:00 AM EDT - 8 months ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Aug 28, 2025, 7:00 AM EDT - 8 months ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 13, 2025, 4:30 PM EDT - 9 months ago

HeartBeam Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 9 months ago

HeartBeam Reports Second Quarter 2025 Results

Jul 30, 2025, 7:00 AM EDT - 9 months ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 22, 2025, 7:00 AM EDT - 10 months ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jun 24, 2025, 2:00 PM EDT - 11 months ago

HeartBeam Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

Jun 17, 2025, 7:00 AM EDT - 11 months ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q1 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 5, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 1, 2025, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Apr 29, 2025, 8:31 AM EDT - 1 year ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 24, 2025, 8:31 AM EDT - 1 year ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q4 2024

Mar 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 1 year ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 1 year ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 1 year ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Sep 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Sep 10, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Names Timothy Cruickshank as Chief Financial Officer

Aug 14, 2024, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:05 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2024 Results

Aug 1, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time

Jul 1, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Added to Russell Microcap® Index

Jun 25, 2024, 9:00 AM EDT - 2 years ago

Epitel Announces Appointment of Wearables Industry Leader Ken Nelson to Board of Directors

May 9, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Earnings Call Transcript: Q1 2024

Mar 20, 2024, 4:30 PM EDT - 2 years ago

HeartBeam Earnings Call Transcript: Q4 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

HeartBeam Earnings Call Transcript: Q3 2023

Aug 10, 2023, 4:30 PM EDT - 2 years ago

HeartBeam Earnings Call Transcript: Q2 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

HeartBeam Earnings Call Transcript: Q1 2023

Mar 16, 2023, 4:30 PM EDT - 3 years ago

HeartBeam Earnings Call Transcript: Q4 2022

Nov 10, 2022, 3:00 PM EST - 3 years ago

HeartBeam Earnings Call Transcript: Q3 2022

BrightStars May. 1 at 6:46 PM

1 · Reply

ACInvestorBlog May. 1 at 5:23 PM

$BEAT could explode higher again

1 · Reply

EddieNoMoney May. 1 at 4:01 PM

4 · Reply

BrightStars May. 1 at 12:35 AM

2 · Reply

Flyhai Apr. 30 at 7:51 PM

$BEAT earnings call/report update on may 13

0 · Reply

BrightStars Apr. 30 at 7:06 PM

0 · Reply

BillionerOfKing Apr. 30 at 6:43 PM

$BEAT Current Stock Price: $0.87

0 · Reply

peekaboo2 Apr. 30 at 6:38 PM

1 · Reply

BrightStars Apr. 30 at 6:33 PM

$BEAT whooo hoooo .87c HA ! POS :-/

1 · Reply

TheRoost3r Apr. 30 at 5:03 PM

$BEAT someone just got "excited" lol

0 · Reply

TheRoost3r Apr. 30 at 3:57 PM

$BEAT hopefully we won't have to wait too much longer as we get closer to the ER May 13th. Date: Wednesday, May 13, 2026 Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time) Dial-in: 1-877-704-4453 International Dial-in: 1-201-389-0920 Conference Code: 13760379 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1761581&tp_key=a64f57a332

1 · Reply

TheRoost3r Apr. 30 at 3:15 PM

$BEAT I'm a patient man

0 · Reply

Oil_Pal Apr. 29 at 9:15 PM

$BEAT added

1 · Reply

TheRoost3r Apr. 29 at 5:07 PM

$BEAT despicable lol

0 · Reply

bennytheboy Apr. 29 at 4:48 PM

$BEAT I still like AIML in this space. More speculative for sure, but looking better than this dog.

0 · Reply

TheRoost3r Apr. 29 at 3:08 PM

$BEAT unfortunately I think we have to wait ... May ER may give us a bump, but think it iwll be a bit longer before they start running on performance

1 · Reply

BrightStars Apr. 29 at 2:13 PM

$BEAT tell me lies tell me sweet little lies tell me lies …tell me tell me lies.

1 · Reply

peekaboo2 Apr. 29 at 2:11 PM

$BEAT They have a much bigger spring board this time around.

0 · Reply

BrightStars Apr. 29 at 2:08 PM

$BEAT will this recover like it did in 2022 or …

0 · Reply

timbr1oak Apr. 28 at 11:09 PM

$BEAT I just received this alert. It seems like a ridiculous pt, but the company that rated them is a wireless medical technology company with deep pockets it seems. Legit?

4 · Reply

Flyhai Apr. 28 at 8:25 PM

$BEAT flipping pennies lol

0 · Reply

TheRoost3r Apr. 28 at 7:54 PM

$BEAT it's a labor of love at this point :(

1 · Reply

Market Cap	35.26M
Revenue (ttm)	0.00
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	673,900
Avg Vol	1,678,722
Day's Range	N/A - N/A
Shares Out	41.09M
Stochastic %K	55%
Beta	-0.63
Analysts	Strong Sell
Price Target	$5.38